Download PDF

Other users also viewed these articles

Position statement on the use of albumin in liver cirrhosis Graciela Castro-Narro; Carlos Moctezuma-Velázquez; Rene Male-Velázquez; Rafael Trejo-Estrada; Francisco Javier Bosques; Rosalba Moreno-Alcántar; Heriberto Rodríguez-Hernández; Aleida Bautista-Santos; Carlos Córtez-Hernández; Eira Cerda-Reyes; Juanita Pérez-Escobar; Juan Manuel Aldana-Ledesma; Jonathan Aguirre-Valadez; José Antonio Velarde Ruiz-Velasco; Raúl Contreras-Omaña; Godolfino Miranda-Zazueta; Monica del Rocío Reyes-Bastidas; Javier Manuel Meza-Cardona; Norberto Chávez-Tapia; Nicolas Joaquín Fernández-Pérez; Edgar Santino García-Jiménez; Aldo Torre;
10.1016/j.aohep.2022.100708
Long-term albumin treatment for decompensated cirrhosis in Italy: A propensity score-matched, retrospective, real-world chart analysis Wim Laleman; Jonel Trebicka; Alastair O¿Brien; Giacomo Zaccherini; Paolo Caraceni; Joana F. Rodrigues; Xiang Zhang; Maebh Kelly; Kyle Rodney; Sofia Schweiger; Paolo Angeli;
Ann Hepatol. 2026;31:
Albumin in the management of hepatic encephalopathy: A systematic review and meta-analysis Bombassaro IS; Isadora Z. Bombassaro; Cristiane V. Tovo; Ângelo Z. de Mattos; Marcelo Ahlert; Talita Chiesa; Angelo A. de Mattos;
Ann Hepatol. 2021;26C: